Sort
46,585 grants matching “heart failure”
Sfrp2 induces in situ c-Kit cell differentiation into cardiomyocytes via Wnt11-Fzd5 mediated b-catenin inhibition
$401,458Victor J Dzau · Duke University · R01 · FY2019 · HL
Cellular Biology of Cardiac Sodium-Calcium Exchange
$401,436Joshua I Goldhaber · Cedars-Sinai Medical Center · R01 · FY2015 · HL
Cardiac Mast Cell: Role in Pathogenesis of Heart Failure
$401,434Auburn University At Auburn · R01 · FY2004 · HL
Home Blood Pressure Telemonitoring and Case Management to Control Hypertension
$401,427Karen L Margolis · Healthpartners Institute · R01 · FY2013 · HL
Synaptic Mechanisms Regulating Sympathetic Drive
$401,406Hui-Lin Pan · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · HL
Intravascular Deployment of a Wirelessly Powered Micro-Pacer
$401,308Tzung K Hsiai · University Of California Los Angeles · R01 · FY2025 · HL
PEDIATRIC CARDIOMYOPATHY REGISTRY
$401,294University Of Miami School Of Medicine · R01 · FY2003 · HL
HIGH-THROUGHPUT IN VIVO SUBCELLULAR-RESOLUTION VERTEBRATE SCREENING PLATFORM
$401,292Mehmet Fatih Yanik · Massachusetts Institute Of Technology · R01 · FY2014 · NS
Age Associated Changes In Structural And Functional Cardio-Vascular Properties
$401,283Edward Lakatta · National Institute On Aging · ZIA · FY2017 · AG
Endogenous Hydrogen Sulfide Enzymes in Heart Failure
$401,281David Joseph Lefer · Lsu Health Sciences Center · R01 · FY2021 · HL
Endogenous Hydrogen Sulfide Enzymes in Heart Failure
$401,281David Joseph Lefer · Lsu Health Sciences Center · R01 · FY2019 · HL
Endogenous Hydrogen Sulfide Enzymes in Heart Failure
$401,281Huijing Xia · Lsu Health Sciences Center · R01 · FY2022 · HL
Endogenous Hydrogen Sulfide Enzymes in Heart Failure
$401,281David Joseph Lefer · Lsu Health Sciences Center · R01 · FY2020 · HL
Genetic association in schizophrenia and other disorders
$401,273Bernie Devlin · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · MH
Genetic association in schizophrenia and other disorders
$401,273Bernie Devlin · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · MH
The role of protease-activated receptor 2 in atherosclerosis
$401,250Albert Phillip Owens III · University Of Cincinnati · R01 · FY2020 · HL
Harnessing novel glucocorticoid biology to treat diabetic cardiomyopathy
$401,250Mattia Quattrocelli · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · HL
INVESTIGATION OF A NEWLY DISCOVERED ORGANELLE-BASED SIGNALING PARADIGM
$401,250Roshanak Irannejad · University Of California, San Francisco · R35 · FY2019 · GM
The role of protease-activated receptor 2 in atherosclerosis
$401,250Albert Phillip Owens III · University Of Cincinnati · R01 · FY2022 · HL
The Dynamics of Human Atrial Fibrillation
$401,250Sanjiv M Narayan · Stanford University · R01 · FY2017 · HL
The Dynamics of Human Atrial Fibrillation
$401,250Sanjiv M Narayan · Stanford University · R01 · FY2019 · HL
Harnessing novel glucocorticoid biology to treat diabetic cardiomyopathy
$401,250Mattia Quattrocelli · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · HL
The role of protease-activated receptor 2 in atherosclerosis
$401,250Albert Phillip Owens III · University Of Cincinnati · R01 · FY2021 · HL
Harnessing novel glucocorticoid biology to treat diabetic cardiomyopathy
$401,250Mattia Quattrocelli · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · HL
Two-Pore Domain Potassium Channels and Aldosterone Secretion
$401,198Paula Q Barrett · University Of Virginia · R01 · FY2009 · HL